Monday, December 22, 2025
News Health

News Health

Adjunctive treatment with the GLP-1 agonist semaglutide significantly reduces the antipsychotic-related cardiometabolic risk in individuals with schizophrenia spectrum disorders compared with placebo. Medscape Medical News Source link : https://www.medscape.com/viewarticle/semaglutide-lowers-antipsychotic-related-cardiometabolic-2025a1000yxa?src=rss Author...

Read more
Page 15 of 172 1 14 15 16 172

Categories

Archives

December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031